mTORC1-dependent signaling pathway underlies the rapid effect of creatine and ketamine in the novelty-suppressed feeding test

FL Pazini, JM Rosa, A Camargo, DB Fraga… - Chemico-Biological …, 2020 - Elsevier
The development of fast-acting antidepressants is crucial considering that conventional
antidepressants require a long period to elicit therapeutic effects. Creatine, an ergogenic …

Nitric oxide and major depressive disorder: pathophysiology and treatment implications

P Kudlow, DS Cha, AF Carvalho… - Current molecular …, 2016 - ingentaconnect.com
Major depressive disorder (MDD) is a multi-factorial and heterogeneous disease. Robust
evidence suggests that inflammation is involved in the pathogenesis of MDD for a …

Antidepressant-like effect of guanosine involves activation of AMPA receptor and BDNF/TrkB signaling

PB Rosa, LEB Bettio, VB Neis, M Moretti… - Purinergic …, 2021 - Springer
Guanosine is a purine nucleoside that has been shown to exhibit antidepressant effects, but
the mechanisms underlying its effect are not well established. We investigated if the …

Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests

A Haj-Mirzaian, N Kordjazy, A Haj-Mirzaian… - …, 2015 - Springer
Rationale The antidepressant action of acute nicotine administration in clinical and animal
studies is well recognized. But the underlying mechanism for this effect has not been …

[HTML][HTML] Novel approaches for the management of depressive disorders

MP Kaster, M Moretti, MP Cunha… - European Journal of …, 2016 - Elsevier
Major depressive disorder is a disabling psychiatric condition that causes a significant
burden on individuals and society. There is still a lack of a clear understanding of the …

The possible beneficial effects of creatine for the management of depression

FL Pazini, MP Cunha, ALS Rodrigues - Progress in Neuro …, 2019 - Elsevier
Depression, a highly prevalent neuropsychiatric disorder worldwide, causes a heavy burden
for the society and is associated with suicide risk. The treatment of this disorder remains a …

Glutamatergic NMDA receptor as therapeutic target for depression

GZ Réus, HM Abelaira, T Tuon, SE Titus… - Advances in protein …, 2016 - Elsevier
Major depressive disorder (MDD) affects approximately 121 million individuals globally and
poses a significant burden to the healthcare system. Around 50–60% of patients with MDD …

Pathologic role of nitrergic neurotransmission in mood disorders

M Ghasemi, J Claunch, K Niu - Progress in Neurobiology, 2019 - Elsevier
Mood disorders are chronic, recurrent mental diseases that affect millions of individuals
worldwide. Although over the past 40 years the biogenic amine models have provided …

Monoaminergic and aminoacidergic receptors are involved in the antidepressant-like effect of ginsenoside Rb1 in mouse hippocampus (CA3) and prefrontal cortex

GL Wang, YP Wang, JY Zheng, LX Zhang - Brain Research, 2018 - Elsevier
Abstract Ginsenoside Rb1 (Rb1), as the major bioactive ingredient of Panax ginseng CA
Meyer, elicited a novel antidepressant-like effect in the forced swim test (FST) in chronic …

Creatine prevents corticosterone-induced reduction in hippocampal proliferation and differentiation: possible implication for its antidepressant effect

FL Pazini, MP Cunha, D Azevedo, JM Rosa… - Molecular …, 2017 - Springer
The benefits of creatine supplementation have been reported in a broad range of central
nervous system diseases, including depression, although the mechanisms underlying these …